麝香保心丸对不稳定型心绞痛PCI 术后患者心功能、炎症反应及心血管不良事件的影响
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R541.4

基金项目:


Effect of Shexiang Baoxin Pills on Heart Function , Inflammatory Reactions and Adverse Cardiovascular Events in Patients with Unstable Angina Pectoris After PCI
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察麝香保心丸对不稳定型心绞痛患者经皮冠状动脉介入术(PCI) 术后心功能、炎症反应 及心血管不良事件的影响。方法:选取120 例行PCI 治疗的不稳定型心绞痛患者,按随机数字表法分为观察组 与对照组,每组60 例。对照组PCI 术后给予常规西药(阿托伐他汀钙片、硫酸氢氯吡格雷片及阿司匹林肠溶 片) 治疗,观察组在对照组基础上给予麝香保心丸治疗,2 组均治疗3 个月、随访6 个月。比较2 组临床 疗效, 心功能指标[左室舒张末期内径(LVEDD)、左室收缩末期内径(LVESD) 及左室射血分 数(LVEF)],炎症指标[血清白细胞介素-6(IL-6)、超敏C-反应蛋白(hs-CRP)]水平,以及心血管不良 事件发生率。结果:治疗后,观察组临床疗效总有效率98.33%,高于对照组90.00% (P<0.05)。2 组 LVEDD、LVESD 均较治疗前缩小(P<0.05),LVEF 均较治疗前增大(P<0.05);观察组LVEDD、LVESD 均 小于对照组(P<0.05),LVEF 大于对照组(P<0.05)。2 组血清IL-6、hs-CRP 水平均较治疗前降低(P< 0.05),观察组血清IL-6、hs-CRP 水平均低于对照组(P<0.05)。随访6 个月,观察组心血管不良事件发生率 1.67%,低于对照组11.67% (P<0.05)。结论:麝香保心丸可有效改善不稳定型心绞痛PCI 术后患者的心功 能,减轻炎症反应,降低心血管不良事件发生率。

    Abstract:

    Abstract:Objective:To observe the effect of Shexiang Baoxin Pills on heart function,inflammatory reactions and adverse cardiovascular events in patients with unstable angina pectoris after percutaneous coronary intervention (PCI). Methods: A total of 120 cases of patients with unstable angina pectoris after PCI were selected and divided into the observation group and the control group according to the random number table method,with 60 cases in each group. After PCI,the control group was treated with routine western medicine including Atorvastatin Calcium Tablets, Clopidogrel Bisulfate Tablets, and Aspirin Enteric- Coated Tablets, and the observation group was additionally treated with Shexiang Baoxin Pills based on the treatment of the control group. Both groups were given treatment for 3 months and follow-up for 6 months. The clinical effects,the heart function indexes including left ventricular end diastolic diameter (LVEDD),left ventricular end-systolic dimension (LVESD) and left ventricular ejection fraction (LVEF),the levels of inflammatory indexes including interleukin- 6 (IL- 6) and high- sensitivity C- reactive protein (hs-CRP),and the incidence of adverse cardiovascular events were compared in the two groups. Results: After treatment,the total clinical effective rate was 98.33% in the observation group,higher than that of 90.00% in the control group (P<0.05). LVEDD and LVESD in the two groups were decreased when compared with those before treatment (P<0.05), and LVEF were increased when compared with those before treatment (P<0.05); LVEDD and LVESD in the observation group were lower than those in the control group (P<0.05),and LVEF was higher than that in the control group (P<0.05). The levels of IL- 6 and hs-CRP in serum in the two groups were decreased when compared with those before treatment (P< 0.05),and the levels of IL-6 and hs-CRP in serum in the observation group were lower than those in the control group (P<0.05). After a 6- month follow- up,the incidence of adverse cardiovascular events was 1.67% in the observation group, lower than that of 11.67% in the control group (P<0.05). Conclusion: Shexiang Baoxin Pills can effectively improve the heart function of patients with unstable angina pectoris after PCI,reduce the inflammatory reactions and the incidence of adverse cardiovascular events.

    参考文献
    相似文献
    引证文献
引用本文

陈杰,朱德文,姜振华.麝香保心丸对不稳定型心绞痛PCI 术后患者心功能、炎症反应及心血管不良事件的影响[J].新中医,2023,55(8):43-47

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-04-25
  • 出版日期:
文章二维码